Protagonist Therapeutics, Inc (PTGX) › Weighted Average Diluted SharesProtagonist Therapeutics, Inc (PTGX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 34.40M2021-12-31: 46.32M2022-12-31: 49.04M2023-12-31: 56.76M2024-12-31: 65.08M2025-12-31: 63.57M63.57M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3163.57M-2.3%2026-02-25From 2025-01-012024-12-3165.08M+14.6%2026-02-25From 2024-01-012023-12-3156.76M+15.7%2026-02-25From 2023-01-012022-12-3149.04M+5.9%2025-02-21From 2022-01-012021-12-3146.32M+34.7%2024-02-27From 2021-01-012020-12-3134.40M—2023-03-15From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)